- 1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 31. [Online ahead of print]JC
- CONCLUSIONS: Stentless PCI with DCB was frequently used in patients undergoing PCI for bypass graft lesions in Japan and was not associated with a significant difference in 1-year clinical outcomes compared with contemporary DES-based PCI strategies.
- Publisher Full Text (DOI)
- Pre-Implant Angiography and Vascular Complications During Microaxial Flow Pump Support. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 28. [Online ahead of print]JC
- Publisher Full Text (DOI)
- Reply: Keeping it Simple or Keeping it Selected? Contextualizing the KISS Trial. [Letter]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2293-2294.JC
- Publisher Full Text (DOI)
- Keeping it Simple or Keeping it Selected? Contextualizing the KISS Trial. [Letter]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2292.JC
- Publisher Full Text (DOI)
- New-Generation Bioresorbable Magnesium Scaffold Late Thrombosis: Optical Coherence Tomography Insights. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2282-2283.JC
- Publisher Full Text (DOI)
- Not All Equal: Residual Cardiac Damage Stratifies Outcomes Following Conduction Disturbances After TAVR. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2277-2279.JC
- Publisher Full Text (DOI)
- First-in-Human Experience With a Novel Pressure-Controlled, Flow-Regulating Extracorporeal Limb Perfusion Device. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2271-2273.JC
- Publisher Full Text (DOI)
- Reduced Blood Pressure Following Radiofrequency Renal Denervation in High Cardiovascular Risk Patients: The SPYRAL AFFIRM Study. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2268-2270.JC
- Publisher Full Text (DOI)
- The SIRONA Study: Equivalence Achieved, Questions Remaining. [Editorial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2262-2264.JC
- Publisher Full Text (DOI)
- 2-Year Patient-Centered and Clinical Outcomes of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease. [Randomized Controlled Trial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2251-2261.JC
- CONCLUSIONS: SCB angioplasty resulted in sustained patient-reported and clinical outcomes comparable to PCB angioplasty through 2 years, with similar patency, revascularization, and safety.
- Publisher Full Text (DOI)
- Practical Approaches to Optimize Procedural Technique for Primary PCI. [Editorial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2247-2250.JC
- Publisher Full Text (DOI)
- Rapid Inflation-Deflation vs Pressure-Optimized Stenting During Primary PCI: The RAPID-POP Trial. [Randomized Controlled Trial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2234-2246.JC
- CONCLUSIONS: Among patients with STEMI undergoing primary PCI, pressure-optimized stent inflation resulted in significantly higher rates of successful reperfusion than conventional stenting and reduced need for post dilation. A trend toward fewer 30-day major adverse cardiovascular events was observed. Larger trials are warranted to assess effects on longer-term clinical outcomes. (RAPID-POP: A Randomized Controlled Trial; NCT06430892).
- Publisher Full Text (DOI)
- Myocardial Bridge and LAD CTO PCI: Incidental Observation or Procedural Landmark? [Editorial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2231-2233.JC
- Publisher Full Text (DOI)
- Impact of Myocardial Bridges on Long-Term Outcomes After Left Anterior Descending Chronic Total Occlusion Recanalization. [Journal Article]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2220-2230.JC
- CONCLUSIONS: MBs are prevalent after LAD CTO recanalization. Although their presence is associated with adverse outcomes, the risk is driven mainly by stent extension into the bridged segment.
- Publisher Full Text (DOI)
- Redo-TAVR With Evolut: The Second Valve Is Only Half the Story. [Editorial]JACC Cardiovasc Interv. 2026 Aug 24; 19(16):2217-2219.JC
- Publisher Full Text (DOI)